D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
The striatum, which is the major component of the basal ganglia in the brain, is regulated in part by dopaminergic input from the substantia nigra. Severe movement disorders result from the loss of striatal dopamine in patients with Parkinson's disease. Rats with lesions of the nigrostriatal dopamine pathway caused by 6-hydroxydopamine (6-OHDA) serve as a model for Parkinson's disease and show alterations in gene expression in the two major output systems of the striatum to the globus pallidus and substantia nigra. Striatopallidal neurons show a 6-OHDA-induced elevation in their specific expression of messenger RNAs (mRNAs) encoding the D 2 dopamine receptor and enkephalin, which is reversed by subsequent continuous treatment with the D 2 agonist quinpirole. Conversely, striatonigral neurons show a 6-OHDA-induced reduction in their specific expression of mRNAs encoding the D 1 dopamine receptor and substance P, which is reversed by subsequent daily injections of the D 1 agonist SKF-38393. This treatment also increases dynorphin mRNA in striatonigral neurons. Thus, the differential effects of dopamine on striatonigral and striatopallidal neurons are mediated by their specific expression of D 1 and D 2 dopamine receptor subtypes, respectively.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The NAc is composed of a vast array of transcriptionally distinct neuronal subtypes, where medium spiny neurons (MSNs) make up the majority (>95%) of the cells (16).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
In the citing paper
“These neurons are defined by their transcriptional profiles, including dopamine receptor 1 (D1) vs. dopamine receptor 2 (D2) expression, substance P and enkephalin, and other enriched genes (16–18).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,725
DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
Fluoro-gold: a new fluorescent retrograde axonal tracer with numerous unique properties
Schmued, L. C., & Fallon, J. H. (1986) · Brain Research · doi:10.1016/0006-8993(86)91199-6 · Cited by 886
Freund, T. F., Powell, J. F., & Smith, A. D. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90294-x · Cited by 865
Hikosaka, O., & Wurtz, R. H. (1983) · Journal of Neurophysiology · doi:10.1152/jn.1983.49.5.1285 · Cited by 808
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Gerfen, C. R., & Scott Young, W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91217-6 · Cited by 658
Self-citationMultiple D2 dopamine receptors produced by alternative RNA splicing
Monsma, F. J., McVittie, L. D., Gerfen, C. R., Mahan, L. C., & Sibley, D. R. (1989) · Nature · doi:10.1038/342926a0 · Cited by 641
Self-citationProjection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin
Kawaguchi, Y., Wilson, C., & Emson, P. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-10-03421.1990 · Cited by 565
Research works printed but not linked: 1
- HONG, J.S., ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY 24: 223 (1980).
Cited by
Items 201–300 of 1,013
Doig, N. M., Moss, J., & Bolam, J. P. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1623-10.2010 · Cited by 233
Identification of Dopamine D1–D3 Receptor Heteromers
Marcellino, D., Ferré, S., Casadó, V., Cortés, A., Le Foll, B., Mazzola, C., Drago, F., Saur, O., Stark, H., Soriano, A., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710349200 · Cited by 232
The neostriatal mosaic: multiple levels of compartmental organization
Gerfen, C. R. (1992) · Advances in Neuroscience and Schizophrenia · doi:10.1007/978-3-7091-9211-5_4 · Cited by 232
Self-citationUpdate on models of basal ganglia function and dysfunction
DeLong, M., & Wichmann, T. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70822-3 · Cited by 231
Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression
Francis, T. C., & Lobo, M. K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.09.007 · Cited by 230
“The NAc is composed of a vast array of transcriptionally distinct neuronal subtypes, where medium spiny neurons (MSNs) make up the majority (>95%) of the cells (16).”
BackgroundLoss of cannabinoid receptors in the substantia nigra in huntington's disease
Glass, M., Faull, R. L. M., & Dragunow, M. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90352-g · Cited by 230
Dopamine receptorsâphysiological understanding to therapeutic intervention potential
Emilien, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00029-7 · Cited by 228
Balanced activity in basal ganglia projection pathways is critical for contraversive movements
Tecuapetla, F., Matias, S., Dugue, G. P., Mainen, Z. F., & Costa, R. M. (2014) · Nature Communications · doi:10.1038/ncomms5315 · Cited by 225
Badiani, A., Oates, M. M., Day, H. E. W., Watson, S. J., Akil, H., & Robinson, T. E. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-24-10579.1998 · Cited by 225
Le Moine, C., & Bloch, B. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00029-2 · Cited by 225
Striatal mechanisms underlying movement, reinforcement, and punishment
Kravitz, A. V., & Kreitzer, A. C. (2012) · Physiology · doi:10.1152/physiol.00004.2012 · Cited by 224
Yan, Z., Feng, J., Fienberg, A. A., & Greengard, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11607 · Cited by 224
Δ FosB Regulates Wheel Running
Werme, M., Messer, C., Olson, L., Gilden, L., Thorén, P., Nestler, E. J., & Brené, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-18-08133.2002 · Cited by 223
Decreased [18F]Spiperone Binding in Putamen in Idiopathic Focal Dystonia
Perlmutter, J. S., Stambuk, M. K., Markham, J., Black, K. J., McGee-Minnich, L., Jankovic, J., & Moerlein, S. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00843.1997 · Cited by 223
Cuellar, T. L., Davis, T. H., Nelson, P. T., Loeb, G. B., Harfe, B. D., Ullian, E., & McManus, M. T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801689105 · Cited by 222
Severity of dysfluency correlates with basal ganglia activity in persistent developmental stuttering
GIRAUD, A. (2008) · Brain and Language · doi:10.1016/j.bandl.2007.04.005 · Cited by 221
Descarries, L., Watkins, K. C., Garcia, S., Bosler, O., & Doucet, G. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961111)375:2<167::aid-cne1>3.0.co;2-0 · Cited by 221
Tran, M. N., Maynard, K. R., Spangler, A., Huuki, L. A., Montgomery, K. D., Sadashivaiah, V., Tippani, M., Barry, B. K., Hancock, D. B., Hicks, S. C., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.09.001 · Cited by 219
Maladaptive striatal plasticity in l-DOPA-induced dyskinesia
Cenci, M. A., & Konradi, C. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)83011-0 · Cited by 216
Homeostasis Meets Motivation in the Battle to Control Food Intake
Ferrario, C. R., Labouèbe, G., Liu, S., Nieh, E. H., Routh, V. H., Xu, S., & O'Connor, E. C. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2338-16.2016 · Cited by 214
Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs
Joyce, J. N. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00139-5 · Cited by 214
Tallaksen-Greene, S. J., Kaatz, K. W., Romano, C., & Albin, R. L. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01141-4 · Cited by 214
Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome
Harris, G. C., & Aston-Jones, G. (1994) · Nature · doi:10.1038/371155a0 · Cited by 214
Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson' disease
Starr, M. S. (1995) · Synapse · doi:10.1002/syn.890190405 · Cited by 214
Durieux, P. F., Schiffmann, S. N., & de Kerchove d'Exaerde, A. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.400 · Cited by 213
Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum
Moratalla, R., Robertson, H., & Graybiel, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02609.1992 · Cited by 213
Angulo, J. A., & McEwen, B. S. (1994) · Brain Research Reviews · doi:10.1016/0165-0173(94)90002-7 · Cited by 212
Lee, C. S. (2000) · Brain · doi:10.1093/brain/123.7.1365 · Cited by 212
Compensatory mechanisms in experimental and human Parkinsonism: towards a dynamic approach
Bezard, E., & Gross, C. E. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00006-9 · Cited by 211
Spangler, R., Unterwald, E. M., & Kreek, M. J. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90133-a · Cited by 211
Gagnon, D., Petryszyn, S., Sanchez, M. G., Bories, C., Beaulieu, J. M., De Koninck, Y., Parent, A., & Parent, M. (2017) · Scientific Reports · doi:10.1038/srep41432 · Cited by 210
Basal ganglia oscillations and pathophysiology of movement disorders
Rivlin-Etzion, M., Marmor, O., Heimer, G., Raz, A., Nini, A., & Bergman, H. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.10.002 · Cited by 210
Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion
Meshul, C. K., Emre, N., Nakamura, C. M., Allen, C., Donohue, M. K., & Buckman, J. F. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00189-4 · Cited by 209
Dopaminergic control of the exploration-exploitation trade-off via the basal ganglia
Humphries, M. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00009 · Cited by 206
“…and lesion studies support this functional split into D1- and D2-dominant projection neurons and, further, that the D1-dominant neurons project to SNr, and the D2-dominant neurons project to GP (Gerfen et al., 1990; Surmeier et al., 2007; Matamales et al., 2009; Humphries and Prescott, 2010).”
BackgroundAnderson, S. M., & Pierce, R. C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.12.004 · Cited by 204
Networking brainstem and basal ganglia circuits for movement
Arber, S., & Costa, R. M. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-022-00581-w · Cited by 202
Calabresi, P., Maj, R., Mercuri, N. B., & Bernardi, G. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90628-k · Cited by 202
Mastro, K. J., Bouchard, R. S., Holt, H. A. K., & Gittis, A. H. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4646-13.2014 · Cited by 202
Nonomura, S., Nishizawa, K., Sakai, Y., Kawaguchi, Y., Kato, S., Uchigashima, M., Watanabe, M., Yamanaka, K., Enomoto, K., Chiken, S., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.08.002 · Cited by 202
Cocaine self-administration differentially alters mRNA expression of striatal peptides
Hurd, Y. L., Brown, E. E., Finlay, J. M., Fibiger, H. C., & Gerfen, C. R. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90058-j · Cited by 200
Self-citationMechanisms of methamphetamine-induced dopaminergic neurotoxicity
Riddle, E. L., Fleckenstein, A. E., & Hanson, G. R. (2006) · The AAPS Journal · doi:10.1007/bf02854914 · Cited by 199
The Spatiotemporal Organization of the Striatum Encodes Action Space
Klaus, A., Martins, G. J., Paixao, V. B., Zhou, P., Paninski, L., & Costa, R. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.10.031 · Cited by 199
Shaping action sequences in basal ganglia circuits
Jin, X., & Costa, R. M. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.06.011 · Cited by 198
Drugs of abuse and immediate-early genes in the forebrain
Harlan, R. E., & Garcia, M. M. (1998) · Molecular Neurobiology · doi:10.1007/bf02741385 · Cited by 198
Milestones in research on the pathophysiology of Parkinson's disease
Wichmann, T., DeLong, M. R., Guridi, J., & Obeso, J. A. (2011) · Movement Disorders · doi:10.1002/mds.23695 · Cited by 197
Neuronal cell death in Huntington’s disease: a potential role for dopamine
Jakel, R. J., & Maragos, W. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01568-x · Cited by 197
Adenosine A2AReceptors are Colocalized with and Activate Golfin Rat Striatum
Kull, B., Svenningsson, P., & Fredholm, B. B. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.4.771 · Cited by 196
Svenningsson, P., Lindskog, M., Ledent, C., Parmentier, M., Greengard, P., Fredholm, B. B., & Fisone, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1856 · Cited by 196
Harvey, J., & Lacey, M. G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05271.1997 · Cited by 196
Ward, R. P., & Dorsa, D. M. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960701)370:3<405::aid-cne10>3.0.co;2-r · Cited by 196
Caffeine and the dopaminergic system
Cauli, O., & Morelli, M. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200503000-00001 · Cited by 195
Reappraising striatal D1- and D2-neurons in reward and aversion
Soares-Cunha, C., Coimbra, B., Sousa, N., & Rodrigues, A. J. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.021 · Cited by 195
Sippy, T., Lapray, D., Crochet, S., & Petersen, C. C. H. (2015) · Neuron · doi:10.1016/j.neuron.2015.08.039 · Cited by 194
Kreiss, D. S., Mastropietro, C. W., Rawji, S. S., & Walters, J. R. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-17-06807.1997 · Cited by 194
Engber, T. M., Susel, Z., Kuo, S., Gerfen, C. R., & Chase, T. N. (1991) · Brain Research · doi:10.1016/0006-8993(91)90667-k · Cited by 194
Self-citationBoraud, T., Bezard, E., Bioulac, B., & Gross, C. E. (2001) · Brain · doi:10.1093/brain/124.3.546 · Cited by 193
Aberman, J. E., Ward, S. J., & Salamone, J. D. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00112-9 · Cited by 193
Svenningsson, P., Le Moine, C., Kull, B., Sunahara, R., Bloch, B., & Fredholm, B. B. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00180-2 · Cited by 193
α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease
Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 192
Nondopaminergic mechanisms in levodopa‐induced dyskinesia
Brotchie, J. M. (2005) · Movement Disorders · doi:10.1002/mds.20612 · Cited by 192
Decoding molecular and cellular heterogeneity of mouse nucleus accumbens
Chen, R., Blosser, T. R., Djekidel, M. N., Hao, J., Bhattacherjee, A., Chen, W., Tuesta, L. M., Zhuang, X., & Zhang, Y. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00938-x · Cited by 191
Striatal microcircuitry and movement disorders
Gittis, A. H., & Kreitzer, A. C. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.06.008 · Cited by 191
Role of Primate Substantia Nigra Pars Reticulata in Reward-Oriented Saccadic Eye Movement
Sato, M., & Hikosaka, O. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02363.2002 · Cited by 191
New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine
Brunello, N. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00068-o · Cited by 191
Twenty-Five Lessons from Computational Neuromodulation
Dayan, P. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.027 · Cited by 190
Caillé, I., Dumartin, B., & Bloch, B. (1996) · Brain Research · doi:10.1016/0006-8993(96)00424-6 · Cited by 190
Boraud, T., Bezard, E., Bioulac, B., & Gross, C. E. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00033-8 · Cited by 189
Guo, Q., Wang, D., He, X., Feng, Q., Lin, R., Xu, F., Fu, L., & Luo, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123381 · Cited by 188
The Dopamine D1-D2 Receptor Heteromer Localizes in Dynorphin/Enkephalin Neurons
Perreault, M. L., Hasbi, A., Alijaniaram, M., Fan, T., Varghese, G., Fletcher, P. J., Seeman, P., O'Dowd, B. F., & George, S. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.159954 · Cited by 188
Moratalla, R., Xu, M., Tonegawa, S., & Graybiel, A. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14928 · Cited by 188
D1 Dopamine Receptor Activation of Multiple Transcription Factor Genes in Rat Striatum
Cole, A. J., Bhat, R. V., Patt, C., Worley, P. F., & Baraban, J. M. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb11358.x · Cited by 188
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
Carlsson, A., Hansson, L. O., Waters, N., & Carlsson, M. L. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00228-2 · Cited by 187
Chemical anatomy of primate basal ganglia
Parent, A. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00001-c · Cited by 187
Anatomy and connectivity of intrastriatal striatal transplants
Wictorin, K. (1992) · Progress in Neurobiology · doi:10.1016/0301-0082(92)90044-f · Cited by 187
Smith, Y., & Villalba, R. (2008) · Movement Disorders · doi:10.1002/mds.22027 · Cited by 186
Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum
Kötter, R. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90037-x · Cited by 186
Antonini, A., Leenders, K. L., Reist, H., Thomann, R., Beer, H.-F., & Locher, J. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540050026010 · Cited by 186
Doucet, J. ‐., Nakabeppu, Y., Bedard, P. J., Hope, B. T., Nestler, E. J., Jasmin, B. J., Chen, J. ‐., Ladarola, M. J., St‐Jean, M., Wigle, N., et al. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01220.x · Cited by 186
Stochastic synaptic plasticity underlying compulsion in a model of addiction
Pascoli, V., Hiver, A., Van Zessen, R., Loureiro, M., Achargui, R., Harada, M., Flakowski, J., & Lüscher, C. (2018) · Nature · doi:10.1038/s41586-018-0789-4 · Cited by 185
Azdad, K., Gall, D., Woods, A. S., Ledent, C., Ferré, S., & Schiffmann, S. N. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.144 · Cited by 185
Liu, J., Nickolenko, J., & Sharp, F. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8537 · Cited by 185
FGF acts as a co-transmitter through adenosine A2A receptor to regulate synaptic plasticity
Flajolet, M., Wang, Z., Futter, M., Shen, W., Nuangchamnong, N., Bendor, J., Wallach, I., Nairn, A. C., Surmeier, D. J., & Greengard, P. (2008) · Nature Neuroscience · doi:10.1038/nn.2216 · Cited by 182
Striatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism
Wang, W., Li, C., Chen, Q., van der Goes, M.-S., Hawrot, J., Yao, A. Y., Gao, X., Lu, C., Zang, Y., Zhang, Q., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87997 · Cited by 182
Self-citationExtrastriatal dopaminergic circuits of the basal ganglia
Rommelfanger, K. S. (2010) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2010.00139 · Cited by 150
Parallel basal ganglia circuits for voluntary and automatic behaviour to reach rewards
Kim, H. F., & Hikosaka, O. (2015) · Brain · doi:10.1093/brain/awv134 · Cited by 181
Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons
Testa, C. M., Standaert, D. G., Landwehrmeyer, G. B., Penney, J. B., & Young, A. B. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903540207 · Cited by 181
Crombag, H. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00243-6 · Cited by 181
Evaluation of animal models of Parkinson's disease for neuroprotective strategies
Emborg, M. E. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.08.004 · Cited by 181
A robot model of the basal ganglia: Behavior and intrinsic processing
Prescott, T. J., Montes González, F. M., Gurney, K., Humphries, M. D., & Redgrave, P. (2006) · Neural Networks · doi:10.1016/j.neunet.2005.06.049 · Cited by 180
Aoyama, S., Kase, H., & Borrelli, E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05848.2000 · Cited by 180
Lévesque, D., Martres, M. P., Diaz, J., Griffon, N., Lammers, C. H., Sokoloff, P., & Schwartz, J. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1719 · Cited by 180
Dopamine and synaptic plasticity in dorsal striatal circuits controlling action selection
Surmeier, D. J., Plotkin, J., & Shen, W. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.10.003 · Cited by 179
Stewart, J., & Druhan, J. P. (1993) · Psychopharmacology · doi:10.1007/bf02246961 · Cited by 179
Role of Dopamine in the Primate Caudate Nucleus in Reward Modulation of Saccades
Nakamura, K., & Hikosaka, O. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4853-05.2006 · Cited by 178
Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease
Augood, S. J., Faull, R. L. M., & Emson, P. C. (1997) · Annals of Neurology · doi:10.1002/ana.410420213 · Cited by 177
Mechanisms for the Modulation of Dopamine D1 Receptor Signaling in Striatal Neurons
Nishi, A., Kuroiwa, M., & Shuto, T. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00043 · Cited by 177
Ade, K. K., Wan, Y., Chen, M., Gloss, B., & Calakos, N. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00032 · Cited by 176
The role of basal ganglia in the control of generalized absence seizures
Deransart, C., Vercueil, L., Marescaux, C., & Depaulis, A. (1998) · Epilepsy Research · doi:10.1016/s0920-1211(98)00053-9 · Cited by 176
Opposing mechanisms mediate morphine- and cocaine-induced generation of silent synapses
Graziane, N. M., Sun, S., Wright, W. J., Jang, D., Liu, Z., Huang, Y. H., Nestler, E. J., Wang, Y. T., Schlüter, O. M., & Dong, Y. (2016) · Nature Neuroscience · doi:10.1038/nn.4313 · Cited by 176
Convergence of Reinforcing and Anhedonic Cocaine Effects in the Ventral Pallidum
Creed, M., Ntamati, N. R., Chandra, R., Lobo, M. K., & Lüscher, C. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.001 · Cited by 176
Metadata
- Authors
- Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R.
- Affiliations
- National Institutes of Health (US)
- Venue
- Science
- Published
- 1990-12-07
- Volume
- 250
- Issue
- 4986
- Pages
- 1429-1432
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1991603311
- Cited by
- 2,967
- References
- 38
- Citations by year
- 2026: 54 · 2025: 60 · 2024: 73 · 2023: 64 · 2022: 89 · 2021: 84 · 2020: 79 · 2019: 85 · 2018: 90 · 2017: 79 · 2016: 102 · 2015: 106 · 2014: 95 · 2013: 79 · 2012: 97
- FWCI
- 27.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- dopamine D1 receptor, dopamine D2 receptor, striatonigral neurons, striatopallidal neurons, gene expression, 6-hydroxydopamine lesion, Parkinson's disease model, substantia nigra, globus pallidus, enkephalin, substance P, dynorphin, quinpirole, SKF 38393, basal ganglia, dopamine agonists
- MeSH terms
- Animals, Cerebral Cortex, Corpus Striatum, Ergolines, Gene Expression Regulation, Globus Pallidus, Hydroxydopamines, Models, Neurological, Neurons, Receptors, Dopamine, RNA, Messenger, Substantia Nigra, Thalamus, Oligonucleotide Probes, 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, Oxidopamine, Receptors, Dopamine D1, Receptors, Dopamine D2, Quinpirole, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.